3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
2
Neuralgia
2
Neoplasms
2
Lung Neoplasms
2
Leiomyoma
2
Sexual Dysfunction, Physiological
1
Scleroderma, Localized
1
Pneumonia
1
Pain
1
Neuropathy, Painful
1
Neurofibromatoses
1
Neurodermatitis
1
Neoplasms, Cystic, Mucinous, and Serous
1
Mastodynia
1
Lymphoma, Follicular
1
Lichen Planus
1
Leukemia-Lymphoma
1
Kidney Neoplasms
1
Keratoacanthoma
1
Keloid
1
Ileus
1
Hydrocephalus
1
Hordeolum
1
Headache
1
Granuloma Annulare
1
Eyelid Neoplasms
1
Epilepsy
1
Dermoid Cyst
1
Colorectal Neoplasms
1
Cold Hypersensitivity
1
Interventions
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
morphine, naltrexone combination
1
Therapeutics
1
Tapentadol
1
Nerve Block
1
Naltrexone
1
Morphine
1
Fentanyl
1
Anesthetics, Local
1
Anesthesia, Local
1
Acceptance and Commitment Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Chronic Pain
×
Lidocaine
×
Clear all
No trials found.